Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Yoshitomi describes potent, selective tryptase inhibitors

July 13, 1999

Cytokine suppressors for immune disorders developed at SS Pharm.

July 13, 1999

LM-1484 should be very effective therapy for bronchial asthma according to preclinical data

July 9, 1999

Plaferone in the treatment of asthma and respiratory infections

July 8, 1999

Benzimidazoles for acute and chronic inflammatory diseases patented by Taiho

July 8, 1999

Zaditen in the treatment of pediatric respiratory disorders

July 7, 1999

Antisense therapy: a novel treatment for asthma

July 7, 1999

New purine PDE4 inhibitors from Mitsubishi useful for asthma Rx

July 7, 1999

Yamanouchi prepares selective inhibitors of Ca2+ release-activated Ca2+ channels (CRACC)

July 7, 1999

Recent advances in gene therapy of cystic fibrosis

July 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...